Call for papers for the 3rd edition of the Lisbon Winter School for the Study of Communication

The Call for Papers for the 3rd edition of the Lisbon Winter School for the Study of Communication is now open until October 10, 2022.

Jointly organized by the Faculty of Human Sciences (Universidade Católica Portuguesa), the Center for Media@Risk at the Annenberg School for Communication (University of Pennsylvania), the School of Journalism and Communication (Chinese University of Hong Kong), the Annenberg School for Communication and Journalism (University of Southern California) and the Faculty of Social Sciences (University of Helsinki), the Lisbon Winter School for the Study of Communication provides students with the opportunity to discuss central topics of communication in a truly international environment.

The 3rd edition, dedicated to the theme "Media and Propaganda", will take place between January 4 and 7, 2023 at the Faculty of Human Sciences.

For more information, check the Lisbon Winter School for the Study of Communication website.

Summer Schools Escola das Artes Faculty of Human Sciences
Summer Schools on Disobedience Bring Together 140 Participants from 30 Countries at Católica
A joint initiative by The Lisbon Consortium and the School of Arts at Universidade Católica took place at its headquarters in Lisbon, attended by students, artists, curators, filmmakers and international researchers. Find out more here.
Católica Research
Católica alumni awarded Fulbright scholarships for 2026/2027
Three alumni of Universidade Católica Portuguesa have been awarded Fulbright scholarships for the 2026/2027 academic year, a distinction that will enable them to carry out research projects and pursue further studies in the United States of America. Find out more here.
Católica Biomedical Research Center Research
CBR Researcher Awarded ERC Proof of Concept Grant to Develop a New Generation of Influenza Antiviral Drugs
Maria João Amorim, a researcher at CBR and associate professor at Católica Medical School, has been awarded a European Research Council (ERC) Proof of Concept (PoC) Grant to develop an innovative approach to combating influenza A virus. Read more.